Segments From this episode
Rising bond yields are an optimistic sign, even though the Fed says a real recovery isn't right around the corner.
Millions would become eligible, and the benefit could triple for some.
Pfizer and others are collaborating to accelerate production. Johnson & Johnson and Novavax may receive FDA approval soon.
Some pivoted to help their communities. Others have received support from their customers.
Inflation’s been hard to find in this economy for years, but what if that changes?
Businesses can only apply for the latest round of loans if their revenue fell 25% or more.